Flora Peyvandi / X
Jun 26, 2025, 12:53
Flora Peyvandi: Chinese Researchers Smoothly Enter the Gene‑Therapy Arena as the Fight for Hemophilia B Heats Up
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, posted on X:
”First Chinese HB gene therapy: ISTH2025”
They say it’s better to prevent than treat—so naturally, ISTH 2025 turned into a gene‑therapy playground for Hemophilia B.
The clinical gene sessions are serving up some seriously insightful management intel!
Stay updated on the latest breakthroughs in Hematology: Hemostasis Today.
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke